Abivax (ABVX) Assets Average (2022 - 2026)

Abivax's Assets Average history runs 4 years deep, the most recent figure standing at $660.4 million for Q1 2026.

• In Q1 2026, Assets Average rose 234.47% year-over-year to $660.4 million; the TTM figure through Mar 2026 stood at $660.4 million (up 234.47% YoY), while the FY2025 annual figure was $449.7 million, up 57.48% from the prior year.
• Assets Average was $660.4 million for Q1 2026 at Abivax, down from $721.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $721.2 million in Q4 2025 to a low of $101.0 million in Q4 2022.
• Historically, Assets Average has averaged $357.0 million across 4 years, with a median of $214.5 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Assets Average surged 112.33% in 2023, then jumped 234.47% in 2026.
• A 4-year view of Assets Average shows it stood at $101.0 million in 2022, then soared by 112.33% to $214.5 million in 2023, then surged by 236.26% to $721.2 million in 2025, then dropped by 8.44% to $660.4 million in 2026.
• The last three Assets Average figures came in at $660.4 million (Q1 2026), $721.2 million (Q4 2025), and $448.9 million (Q3 2025), per Business Quant data.